NCT07452224
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07452224
Title ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors iLeukon Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Valkyrie Clinical Trials, Inc RECRUITING Los Angeles California 90067 United States Details
Start Ccbd, Llc RECRUITING Fort Worth Texas 76104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field